Steven J. Yakubov, MD, FACC, MSCAI

System/Medical Chief - Structural Heart Disease
OhioHealth/Riverside Methodist Hospital
Columbus, Ohio, United States

Steven J Yakubov, MD, FACC, MSCAI is recognized nationally as a leader in cardiovascular innovation and research. He has been involved in more than 100 clinical trials to pioneer the latest and most advanced treatment options for cardiovascular disease. Dr Yakubov is the Medical Director of the OhioHealth Research Institute and the John H. McConnell Chair of Advanced Structural Heart Disease and currently the principal investigator on several therapeutic devices for structural heart conditions. As system Chief of the OhioHealth Advanced Structural Heart Disease program, he leads its multidisciplinary team of specialists representing cardiology, electrophysiology, interventional cardiology, cardiac surgery, radiology, cardiovascular imaging and anesthesia.

Presentation(s):

• VALVE COMPLICATIONS AND MANAGEMENT | SESSION ONE

  Saturday, February 25, 2023
  2:00 PM – 3:30 PM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)

• VALVE COMPLICATIONS AND MANAGEMENT | SESSION TWO

  Saturday, February 25, 2023
  3:30 PM – 4:30 PM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)

• CARDIOTUBE INTERVIEW: LBT: 5 years outocme rom Surtavi and Corevalve Studies

  Sunday, February 26, 2023
  9:15 AM – 9:25 AM ET

  Disclosure information not submitted.

• A Novel Polymer TAVR: Validation Of Design Considerations From Bench To Chronic Ovine Model

  Sunday, February 26, 2023
  2:12 PM – 2:20 PM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)

• Live Case from University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania

  Monday, February 27, 2023
  10:00 AM – 10:40 AM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)

• Live Case from MedStar Washington Hospital Center | Washington, DC

  Monday, February 27, 2023
  10:40 AM – 11:20 AM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)

• LATE-BREAKING TRIALS | SESSION THREE

  Monday, February 27, 2023
  11:30 AM – 12:30 PM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)

• Five-Year Incidence of Bioprosthetic Valve Dysfunction in Patients Randomized to Surgery or TAVR: Insights from the CoreValve US Pivotal and SURTAVI Trials

  Monday, February 27, 2023
  11:30 AM – 11:40 AM ET

  Disclosure(s): BioStar: Consultant (Ongoing); Boston Scientific: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Foldax: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)